LESLIE WOJTOWICZ: Open Payments
NPI 1861421679 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,666 in 73 payments from 10 companies in 2025. Trend: 2023 $4,314 · 2024 $3,978 · 2025 $2,666
Food & beverage: $2,666
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 21 | $1,103 |
| Gilead Sciences, Inc. | 24 | $784 |
| Intercept Pharmaceuticals, Inc. | 5 | $204 |
| Ipsen Biopharmaceuticals, Inc | 9 | $187 |
| ABBVIE INC. | 4 | $155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 2 | $70 |
| Novo Nordisk Inc | 2 | $46 |
| ORPHALAN INC | 1 | $17 |
| Mirum Pharmaceuticals, Inc. | 1 | $17 |
Products named: REZDIFFRA, Vemlidy, OCALIVA, IQIRVO, MAVYRET, Livdelzi, XIFAXAN, Wegovy.
Industry payments across AZ — which companies pay providers there.
